[Translated article] Safe administration of noradrenaline by the peripheral route: A systematic review
Farmacia Hospitalaria · 2025-01 · 49 (1) · T46-T52
DOI: 10.1016/j.farma.2024.07.004 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Farmacia Hospitalaria, 2025-01. Verfasst von F Dámaso Fernández-Ginés und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Farmacia, Hospital Universitario Torrecárdenas, Almería, Spain. Hauptthemen laut MEDLINE: Norepinephrine, Vasoconstrictor Agents, Catheterization, Peripheral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
PURPOSE: To review and analyse the available literature on peripheral administration of noradrenaline (NA) with the aim of providing recommendations to ensure correct use and patient safety. METHODS: Systematic review on the databases PubMed, ISI Web of Science, SCOPUS, and Science Direct, using the following search terms: ("Noradrenaline" [Mesh]) AND ("Norepinephrine" [Mesh]) AND ("Vasopressors" [Mesh]) AND ("Peripheral infusions" [Mesh]) OR ("Extravasations" [Mesh]). A total of 1040 articles were identified. Animal studies and studies written in languages other than English were excluded. Finally, 83 articles were included. RESULTS: NA can be administered peripherally. The risk of extravasation should be taken into account, with phentolamine being the first pharmacological line of treatment. It has also been related to the appearance of thrombophlebitis, cellulitis, tissue necrosis, limb ischaemia, and gangrene, although its incidence seems to be low. The use of peripheral NA in children seems to be carried out without obvious complications. The use of standard concentrations is suggested to reduce the risk of errors. It is recommended to use 0.9% saline as the default diluent for peripheral NA. CONCLUSIONS: Peripheral infusions of NA could be a safe and beneficial option in early resuscitation provided that a number of guidelines are followed that reduce the likelihood of complications associated with this route.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Farmacia, Hospital Universitario Torrecárdenas, Almería, Spain.
- Servicio de Farmacia, Hospital de Baza, Granada, Spain. Electronic address: btaustehernandez@gmail.com.
- Departamento de anestesiología y manejo del dolor, Hospital Virgen de las Nieves, Granada, Spain.
- Departamento de anestesiología y manejo del dolor, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Zitieren
APA
Fernández-Ginés, F. D., Gómez Sánchez, M. T., Sánchez Valera, M., Tauste Hernández, B., Garrido Ortiz, M., & Cortiñas-Sáenz, M. (2025). [Translated article] Safe administration of noradrenaline by the peripheral route: A systematic review. Farmacia Hospitalaria, 49(1), T46-T52. https://doi.org/10.1016/j.farma.2024.07.004
Vancouver
Fernández-Ginés FD, Gómez Sánchez MT, Sánchez Valera M, Tauste Hernández B, Garrido Ortiz M, Cortiñas-Sáenz M. [Translated article] Safe administration of noradrenaline by the peripheral route: A systematic review. Farmacia Hospitalaria. 2025;49(1):T46-T52. doi:10.1016/j.farma.2024.07.004
BibTeX
@article{FernndezGins2025,
author = {Fernández-Ginés, F Dámaso and Gómez Sánchez, María T and Sánchez Valera, Marina and Tauste Hernández, Beatriz and Garrido Ortiz, Marta and Cortiñas-Sáenz, Manuel},
title = {[Translated article] Safe administration of noradrenaline by the peripheral route: A systematic review},
journal = {Farmacia Hospitalaria},
year = {2025},
volume = {49},
number = {1},
pages = {T46--T52},
doi = {10.1016/j.farma.2024.07.004}
}
EUVIMED